Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals - Image 1

£61.24

CRC Press Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals

Name: Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals
Brand: CRC Press
Price: 61.24 GBP
Availability: InStock

9780367644451

Other Branches of Medicine

This is the most expensive it has ever been. Walk away.

£61 today · previous high £61 · all-time low £57

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 42 days • 42 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 42 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £57 (17 days, 40.5%)

Price range: £57 - £61

Price levels: 4 different prices over 42 days

Description

Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals provides scientists responsible for the translation of novel biopharmaceuticals into clinical trials with a better understanding of how to navigate the obstacles that keep innovative medical research discoveries from becoming new therapies or even making it to clinical trials. The book includes sections on protein-based therapeutics, modified proteins, oligonucleotide-based therapies, monoclonal antibodies, antibody–drug conjugates, gene and cell-based therapies, gene-modified cell-based therapies, combination products, and therapeutic vaccines. Best practices are defined for efficient discovery research to facilitate a science-based, efficient, and predictive preclinical development program to ensure clinical efficacy and safety. Key Features: Defines best practices for leveraging of discovery research to facilitate a development program Includes general principles, animal models, biomarkers, preclinical toxicology testing paradigms, and practical applications Discusses rare diseases Discusses "What-Why-When-How" highlighting different considerations based upon product attributes. Includes special considerations for rare diseases About the Editors Joy A. Cavagnaro is an internationally recognized expert in preclinical development and regulatory strategy with an emphasis on genetic medicines.. Her 40-year career spans academia, government (FDA), and the CRO and biotech industries. She was awarded the 2019 Arnold J Lehman Award from the Society of Toxicology for introducing the concept of science-based, case-by-case approach to preclinical safety evaluation, which became the foundation of ICH S6. She currently serves on scientific advisory boards for advocacy groups and companies and consults and lectures in the area of preclinical development of novel therapies. Mary Ellen Cosenza is a regulatory toxicology consultant with over 30 years of senior leadership experience in the biopharmaceutical industry in the U.S., Europe, and emerging markets. She has held leadership position in both the American College of Toxicology (ACT) and the International Union of Toxicology (IUTOX) and is also an adjunct assistant professor at the University of Southern California where she teaches graduate-level courses in toxicology and regulation of biologics.

Product Specifications

Brand: CRC Press
Model: 9780367644451
Format: paperback
ASIN: 0367644452
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain: Amazon UK
Release Date: 27 May 2024
Listed Since: 29 March 2024

Barcode

No barcode data available

CRC Press Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals

Toxicological Aspects of Medical Device Implants

Lu's Basic Toxicology: Fundamentals, Target Organs, and Risk Assessment, Sixth Edition

Encyclopedia of Drug Metabolism and Interactions, 6 Volume Set

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

Practical Toxicology: Evaluation, Prediction, and Risk, Third Edition

Trends in Development of Medical Devices

Advances in Bioactivation Research: IX (Biotechnology: Pharmaceutical Aspects, IX)

High-Throughput Screening Methods in Toxicity Testing

Current Topics in Nonclinical Drug Development: Volume 2

In Vitro Toxicology Systems (Methods in Pharmacology and Toxicology)

Cellular and Molecular Toxicology: 14 (Comprehensive Toxicology): Volume 14

Humana Drug Safety Evaluation: Methods and Protocols 691

Casarett & Doull's Toxicology: The Basic Science of Poisons, Ninth Edition (PHARMACOLOGY)

Academic Press Advances in Molecular Toxicology Vol 11

Advances in Molecular Toxicology: Volume 9

The Toxicologist's Pocket Handbook

Computational Systems Toxicology (Methods in Pharmacology and Toxicology)

Regulatory Toxicology in the European Union: Volume 36 (Issues in Toxicology)

Introduction to Toxicological Screening Methods and Good Laboratory Practice

CRC Press Mechanistic Toxicology 2nd Edition Textbook

Brainstorming Questions in Toxicology

Introduction to Toxicology

Biomedical Product and Materials Evaluation: Standards and Ethics (Woodhead Publishing Series in Biomaterials)